Home

Market Capitalization of Pharmaids Pharmaceuticals Ltd

Image

Pharmaids Pharmaceuticals Ltd

NSE: PHARMAIDSPHARMA

Market Cap

₹ 246.84 crore

Last updated on: Mar 13, 2025

Key Highlights

  • The Market Cap of Pharmaids Pharmaceuticals Ltd is ₹ 246.84 crore as of 13 Mar 25 .
  • The Latest Trading Price of Pharmaids Pharmaceuticals Ltd is ₹ 69.99 as of 13 Mar 15:30 .
Image

Pharmaids Pharmaceuticals Ltd

NSE: PHARMAIDSPHARMA

Share Price

₹ 69.99

-0.26 (-0.37%)

stock direction

Last updated on: Mar 13, 2025

Market Price of Pharmaids Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Pharmaids Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Mar 202569.99
12 Mar 202570.25
11 Mar 202569.55
10 Mar 202569.38
07 Mar 202572.44
06 Mar 202569.63
05 Mar 202570.69
04 Mar 202568.33
03 Mar 202567.5
28 Feb 202568.73

BlinkX Score for Pharmaids Pharmaceuticals Ltd

Asset Value vs Market Value of Pharmaids Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Pharmaids Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Pharmaids Pharmaceuticals Ltd

  • Pharmaids Pharmaceuticals Limited, incorporated in March, 1989 at Hyderabad, Telangana are the suppliers of Quality Grade range of speciality chemicals, skin care, hospital care and generic products in the areas of Orthopedic, Neuro and Gastro etc.
  • The technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygiene standards.
  • The Company is primarily engaged in business of manufacturing of Generics, Bulk Drugs in various forms like tablets, capsules, liquids and powders etc., in allopathic and herbal Ayurvedic and Natural drug formulation. Emergent Bio Naturals Limited (EBNL) was amalgamated with the Company in 2019-20 and the Scheme of Amalgamation was effective on September 27, 2019.
  • Pursuant to the Scheme, 69,05,734 Equity Shares were allotted to Shareholders of Emergent Bio Naturals Limited on November 27, 2019.

Pharmaids Pharmaceuticals Ltd News Hub

Pharmaids Pharmaceuticals to convene board meeting

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 August

Read more

21 Aug 24

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.68 crore in the June 2024 quarter

Net Loss of Pharmaids Pharmaceuticals reported to Rs 2.68 crore in the quarter ended June 2024 as ag

Read more

14 Aug 24

Pharmaids Pharmaceuticals schedules board meeting

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August

Read more

07 Aug 24

Pharmaids Pharmaceuticals AGM scheduled

Pharmaids Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company will b

Read more

03 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Pharmaids Pharmaceuticals Ltd Market Cap

What is the market cap of Pharmaids Pharmaceuticals Ltd?

As of March 14, 2025, Pharmaids Pharmaceuticals Ltd has a market capitalization of ₹246.84, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Pharmaids Pharmaceuticals Ltd's market capitalization?

Pharmaids Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Pharmaids Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Pharmaids Pharmaceuticals Ltd's market capitalization change?

Pharmaids Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions